Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome. Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.
Viral Vector Production Unit
Spring School 2019 Report
NVCGT Spring Symposium meeting report
Changing Modern Medicine - 2018 ESGCT | ISSCR | SFTCG Congress meeting report
Spring School meeting report
Copyright ©2016 European Society of Gene and Cell Therapy | Website by OFEC